Johnson & Johnson subsidiary Biologics Delivery Systems Group, Cordis of Miami Lakes, FL, said it plans to open a research and development facility in the San Francisco Bay Area.
The firm's newly appointed chief technology officer (CTO), Dr. Campbell Rogers, will be responsible for the center and will direct its strategic planning, Cordis said.
By AuntMinnie.com staff writers
May 25, 2006
Related Reading
Cordis releases Smart stent, May 16, 2006
Biosense Webster, Cordis get Noga XP FDA clearance, March 16, 2006
Cordis launches Palmaz Blue stent in U.S., July 1, 2005
Cordis debuts Tempo Aqua catheter, June 14, 2005
FDA approves Cypher stent with MRI scans, April 21, 2005
Copyright © 2006 AuntMinnie.com